Background {#Sec1}
==========

Total knee arthroplasty (TKA) is a reliable and effective surgical treatment for end-stage knee arthritis. However, prosthesis loosening and osteolysis are major complications affecting the long-term survival of total knee prostheses \[[@CR1], [@CR2]\]. In clinical practice, younger and more active patients can experience early-onset osteolysis and extreme polyethylene wear \[[@CR3]\]. Polyethylene wear has long been associated with osteolysis and prosthesis loosening in TKA \[[@CR4]--[@CR7]\]. Therefore, many studies have been conducted to introduce new designs and materials to reduce polyethylene wear and osteolysis with a goal of achieving better long-term results.

Mobile-bearing TKA was designed to reduce the peak loading stress and backside wear that was responsible for polyethylene wear in fixed-bearing designs \[[@CR8], [@CR9]\]. However, several high-quality studies indicated that the mobile-bearing designs did not result in better radiographic and clinical TKA outcomes. The superiority of mobile bearings was purely theoretical \[[@CR10]--[@CR13]\]. Highly cross-linked polyethylene (HXLPE), a modified form of conventional polyethylene, has a higher cross-link density achieved by irradiation. In recent years, HXLPE acetabular liners for total hip arthroplasty (THA) have successfully decreased linear wear and resulted in less osteolysis compared with conventional polyethylene (CP) \[[@CR14], [@CR15]\]. The superior performance of HXLPE in THA has led to its use in TKA. However, the process of cross-linking the polyethylene to improve wear had the negative effect of decreasing the mechanical properties of the highly cross-linked polyethylenes and adding free radicals to the polyethylene, which can lead to in vivo oxidation \[[@CR16]\]. Additionally, one of the reasons attributed to the failure of HXLPE in TKA is that wear mechanisms in the knee are not exactly same as those in the hip \[[@CR17]\]. Delamination, cracking, fatigue fracture, pitting, etc. are more common in TKA.

Some clinical studies reported inconsistent results in TKA using HXLPE \[[@CR3], [@CR17]--[@CR21]\]. Consequently, the decision of whether to use HXLPE or conventional polyethylene remains controversial. To determine the effectiveness of HXLPE in primary TKA, there is a need for a comprehensive meta-analysis of large sample size randomized control trials (RCTs) and non-RCTs on the subject.

We hypothesized that, compared with conventional polyethylene, HXLPE would be associated with superior clinical and radiographic outcomes in primary TKA. The purpose of this study was to determine whether HXLPE improves postoperative outcomes compared with conventional polyethylene in TKA surgery.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

Potential candidate articles were identified by searching the Cochrane Library, Medline (1966--2015.10), PubMed (1966--2015.10), Embase (1980--2015.10), and ScienceDirect (1985--2015.10) databases. "Gray studies" were identified from the reference lists of included articles so that relevant studies were not missed. No language was restricted. The key words "knee replacement OR arthroplasty," "crosslink," and "polyethylene" were used in combination with the Boolean operators AND or OR.

Inclusion criteria {#Sec4}
------------------

Studies were considered eligible for inclusion if they met the following criteria: (1) the patients underwent primary TKA; (2) the intervention was the use of HXLPE compared to CP (Table [1](#Tab1){ref-type="table"}); (3) the outcomes included clinical outcomes, radiographic outcomes, complication, and revision reason; and (4) the study was a published or unpublished controlled clinical trial.Table 1Characteristics of included studiesStudyStudy designGroupSimple sizeAge (year)Gender (M/F)BMIManufactureDevices informationFollow-upLost follow-upHodrick et al. 2008 \[[@CR3]\]CCTXLPE10067 ± 1242/58NSCompression-molded polyethylene sterilized with ethylene oxide gas preheated at 125°m and irradiated with a dose 9.5 Mrad (95 kGy) through an electron beam.Natural knee II system (Zimmer)Mean 75 months18CP10070 ± 1240/60NSCompression-molded polyethylene, which was gamma-irradiated in nitrogen.Mean 82 months17Minoda et al. 2009 \[[@CR21]\]CCTXLPE8970.3 ± 8.919/70NSGUR 1050 UHMWPE bar cross-linked by subjection of 65 kGy of electron beam with thermal treatment above melting point, and were sterilized by gas plasma.NexGen CR. Zimmer)2 years0CP11371.1 ± 7.320/93NSNet-shape molding of GUR 1050 resin and sterilized by gamma radiation in nitrogen at a dose of 37 kGy.0Lachiewicz and Soileau 2015 \[[@CR19]\]RCTXLPE11068 ± 1035/7531Electron beam, 6.5 CGy irradiated in nitrogen, remelted to quench the free radicals; then sterilized by ethylene oxideZimmer, Inc, Warsaw, IN, USAMinimum 2 years14CP12270 ± 1037/8531Gamma-irradiated in nitrogen21Meneghini et al. 2015 \[[@CR20]\]PCTXLPE6463.818/2931.5GUR 1020 UHMWPE and cross-linking was performed with a cycled process of gamma-irradiation at 30 kGy followed by annealing at 130 °C for 8 h, which was repeated 3 times sequentiallyPosterior-substituting single-radius design (Triathlon; Stryker, Mahwah, NJ)5.2 years (range, 4.3--5.8 years).10CP5067.312/2531.1Compression-molded GU 1020 UHMWPE, packed in nitrogen and gamma-irradiated at 30 kGy.5.5 years (range, 4.8--7.4 years)Kim and Park 2014 \[[@CR17]\]RCTXLPE30860.3 ± 4.320/28829.1Machined from GUR1050 resin bar.NexGen Legacy Posterior-stabilized (LPS)-Flex total knee prosthesis (Zimmer,Warsaw, Indiana)59 years (range, 5--6.8 years)0CP30860.3 ± 4.320/28829.1Machined from GUR1050 resin bar, cross-linked by a 65-kGy electron beam0Kindsfater et al. 2015 \[[@CR18]\]RCTXLPE47766.4 ± 8.535.4 %/64.6 %32.6NSP.F.C. Sigma fixed-bearing knees (DePuy Synthes Joint Reconstruction, Warsaw, IN).5-year298CP44966.3 ± 8.535.4 %/64.6 %33.2NS260

Exclusive criteria {#Sec5}
------------------

We excluded articles that (1) duplicate reports of earlier trials or post hoc analyses of data; (2) articles without an available full-text version; (3) no available outcome data; and (4) non-English-language articles.

Selection criteria {#Sec6}
------------------

Two reviewers independently conducted the search process. Subsequently, the full text of the studies that potentially met the inclusion criteria were read, and the literature was reviewed to determine the final inclusion. Disagreements were resolved though consultation with a third reviewer.

Quality assessment {#Sec7}
------------------

Quality assessment of the randomized trials was conducted using a modification of the generic evaluation tool used by the Cochrane Bone, Joint and Muscle Trauma Group \[[@CR22]\]; the index for non-randomized studies (MINORS) form was used for the non-randomized clinical trials \[[@CR23]\]. The methodological quality of each trial was scored from 0 to 24. Disagreements were resolved by consensus or consultation with the senior reviewer.

Data extraction {#Sec8}
---------------

Two researchers independently extracted the data from the included articles. In cases of incomplete data, the corresponding author was contacted to provide the missing details. The following information was extracted from the articles: first author name, publication year, intervening measures, comparable baseline, sample size, and outcome measures. Other relevant parameters were also extracted from individual studies.

Data analysis and statistical methods {#Sec9}
-------------------------------------

The pooled data were analyzed using RevMan 5.1 software (The Cochrane Collaboration, Oxford, UK). Heterogeneity was estimated based on the values of *P* and *I*^2^ using a standard chi-square test. When *I*^2^ \> 50 %, *P* \< 0.1 was considered to be significant heterogeneity; in this case, a random-effects model was applied for data analysis. A fixed-effects model was used when no significant heterogeneity was found. In cases of significant heterogeneity, subgroup analysis was performed to identify the sources of the heterogeneity. For continuous data, mean differences (MDs) and 95 % confidence intervals (CIs) were calculated. Risk differences (RD) and 95 % CIs were calculated for dichotomous data.

Results {#Sec10}
=======

Search results {#Sec11}
--------------

A total of 153 potentially relevant studies were identified. No additional studies were identified after review of the references. After browsing the titles and abstracts and reviewing the full text, three non-RCTs and three RCTs were eligible for data extraction and were included in the meta-analysis. The articles were published between 2008 and 2015, and they each specified detailed inclusion criteria. The search process is illustrated in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Flowchart of the study selection process

Risk of bias assessment {#Sec12}
-----------------------

The assessment of RCT quality was based on the Cochrane Handbook for Systematic Review of Interventions (Fig. [2](#Fig2){ref-type="fig"}). All RCTs stated clear inclusion criteria, and two of them provided a methodology of randomization; they stated that the method of randomization was the closed envelope technique. A blinding assessor was provided in all RCTs. One of the RCTs attempted to blind the participants or the surgeon. No studies had unclear bias due to incomplete outcome data or selective outcome reporting. For the non-RCTs \[[@CR13]--[@CR16]\], the MINORS score was 16--18 for the retrospectively controlled trials. The methodological quality assessment is illustrated in Table [2](#Tab2){ref-type="table"}.Fig. 2Risk of bias summary of randomized control trialsTable 2Quality assessment for non-randomized trialsQuality assessment for non-randomized trialsHodrick et al. 2008 \[[@CR3]\]Minoda et al. 2009 \[[@CR21]\]Meneghini et al. 2015 \[[@CR20]\]A clearly stated aim222Inclusion of consecutive patients222Prospective data collection112Endpoints appropriate to the aim of the study111Unbiased assessment of the study endpoint111A follow-up period appropriate to the aims of study222Less than 5 % loss to follow-up020Prospective calculation of the sample size000An adequate control group222Contemporary groups111Baseline equivalence of groups222Adequate statistical analyses222Total score161817

Study characteristics {#Sec13}
---------------------

The demographic characteristics and details of the included studies are summarized in Table [1](#Tab1){ref-type="table"}. Only patients diagnosed with end-stage arthritis were enrolled. Statistically similar baseline characteristics were observed between two groups. The experimental group used HXLPE, while the control group used CP. The design of the knee prosthesis varied among the different studies, but all used a medial parapatellar surgical approach. Standard rehabilitation methods were used in all studies.

Outcomes for meta-analysis {#Sec14}
--------------------------

### Total reoperations {#Sec15}

All of the studies reported the overall incidence of reoperation. There was no significant heterogeneity among the studies (*χ*^2^ = 9.37, df = 5, *I*^2^ = 47 %, *P* = 0.10), so a fixed-effects model was utilized. Pooling resulted in no significant difference between the two groups (RD = −0.01, 95 % CI −0.02 to 0.00, *P* = 0.11; Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Forest plot diagram showing total reoperations between two groups

### Reoperation for prosthesis loosening {#Sec16}

Reoperation for prosthesis loosening was reported in five studies. No significant heterogeneity was identified, so a fixed-effects model was applied (*χ*^2^ = 5.21, df = 4, *I*^2^ = 23 %, *P* = 0.27). There was no significant difference between the two groups (RD = −0.01, 95 % CI −0.01 to 0.00, *P* = 0.08; Fig. [4](#Fig4){ref-type="fig"}).Fig. 4Forest plot diagram showing reoperation for prosthesis loosening between two groups

### Radiolucent line {#Sec17}

A radiolucent line was reported in four studies. No significant heterogeneity was found, so a random-effects model was applied (*χ*^2^ = 13.81, df = 3, *I*^2^ = 78 %, *P* = 0.003). There was no significant difference between the two groups (RD = −0.05, 95 % CI −0.13 to 0.04, *P* = 0.20; Fig. [5](#Fig5){ref-type="fig"}).Fig. 5Forest plot diagram showing radiolucent line between two groups

### Osteolysis {#Sec18}

Osteolysis was reported in five studies. No significant heterogeneity was found, so a fixed-effects model was used (*χ*^2^ = 2.70, df = 4, *I*^2^ = 0 %, *P* = 0.61). There was no significant difference between the two groups (RD = −0.0, 95 % CI −0.01 to 0.01, *P* = 0.38).

### Prosthesis loosening {#Sec19}

Four articles reported the incidence of prosthesis loosening after surgery. A fixed-effects model was used because of low significant heterogeneity (*χ*^2^ = 6.06, df = 3, *I*^2^ = 51 %, *P* = 0.11). No significant difference was observed between the groups (RD = −0.01, 95 % CI −0.01 to 0.00, *P* = 0.10).

### Mechanical failures related to the tibial polyethylene {#Sec20}

Three studies described mechanical failures related to the tibial polyethylene. No significant heterogeneity was shown between pooling results; thus, a fixed-effects model was utilized (*χ*^2^ = 0.0, df = 2, *I*^2^ = 0 %, *P* = 1.00). A significant difference was observed between the groups in terms of length of hospital stay (RD = 0.00, 95 % CI −0.01 to 0.01, *P* = 1.00).

### Postoperative total knee score {#Sec21}

The postoperative total knee score was reported in three studies. No significant heterogeneity was found, so a fixed-effects model was used (*χ*^2^ = 0.28, df = 2, *I*^2^ = 0 %, *P* = 0.87). No significant difference was observed between the groups (MD = −0.61, 95 % CI −1.49 to 0.28, *P* = 0.18).

### Postoperative functional score {#Sec22}

Three studies reported a postoperative functional score. No significant heterogeneity was shown between the pooled results, and, thus, a fixed-effects model was utilized (*χ*^2^ = 0.36, df = 2, *I*^2^ = 0 %, *P* = 0.84). There was no significant difference between the groups in terms of postoperative functional score (MD = 1.61, 95 % CI −1.02 to 4.25, *P* = 0.23).

Discussion {#Sec23}
==========

The most important finding of this meta-analysis was that, compared with CP, HXLPE did not decrease the incidence of a postoperative radiolucent line, osteolysis, prosthesis loosening, or reoperation after TKA. XLPE did not improve postoperative clinical outcomes in American Knee Society Knee score based on the results; XLPE showed no advantage over CP in TKA.

Polyethylene wear and subsequent osteolysis in total joint arthroplasty could result in patient dissatisfaction and short survivorship of the prosthetic implant, which increases the medical burden. HXLPE successfully decreased polyethylene wear, osteolysis, and revision rates in THA; however, the wear mechanisms and particle debris occurring in TKA differ substantially from those in THA \[[@CR17]\]. In vitro studies showed that HXLPE positively affected the wear characteristics in TKA \[[@CR24], [@CR25]\]; as a result, many orthopedists adopted HXLPE to solve wear and related problems in TKA. To date, the potential benefits of HXLPE have not been confirmed in the published research. Although a few reviews of the biomechanical and clinical evidence for HXLPE in TKA have been published, they did not extract data for further quantitative analysis \[[@CR26], [@CR27]\]. To our knowledge, this is the first quantitative large sample size meta-analysis to study HXLPE in TKA by only including studies with appropriate control and study groups.

Wear of the polyethylene liner generates particles that induce osteolysis. Studies have reported that HXLPE generates smaller particles than CP \[[@CR5]\]. These smaller particles may be more biologically active and theoretically could lead to more osteolysis \[[@CR28]--[@CR30]\]. The frequency of periprosthetic osteolysis after TKA has been reported to be 5 to 20 % over a follow-up period of 5 to 15 years \[[@CR7], [@CR31], [@CR32]\]. In our meta-analysis of five studies, no significant difference was found in the incidence of osteolysis, which was 0.29 % in the HXLPE group and 0.69 % in the CP group. The incidence of osteolysis was lower than that reported previously, probably because the follow-up periods of the studies included in the meta-analysis (2--6 years) were relatively shorter than in previous reports. Increased osteolysis may be observed in patients over longer-term follow-up.

The reasons for reoperation after TKA included polyethylene wear, prosthesis loosening, periprosthetic infection, mal-alignment, instability, arthrofibrosis, and periprosthetic fracture \[[@CR33], [@CR34]\]. In our meta-analysis, no significant difference was observed in the incidence of reoperation between groups. For HXLPE, we are more concerned about reoperation performed for prosthesis loosening. The results of the meta-analysis showed that, compared with CP, HXLPE did not decrease the incidence of prosthesis loosening and related reoperations with short- or middle-term follow-up. It is important to note that prosthesis loosening and related reoperations would increase with longer-term follow-up.

Postoperative knee function is another important index to assess the effect of HXLPE in TKA. Because different scoring systems were used, we counted the scoring systems as completely as possible. The pooled results indicated that HXLPE did not result in improved KSS knee and KSS function. In Kim's study, the two groups did not differ significantly in terms of postoperative WOMAC scores, patient satisfaction assessed on a visual analog scale, and UCLA activity score \[[@CR17]\]. Two of the included studies also found no significant difference in ROM between the two groups \[[@CR3], [@CR21]\]. We concluded that HXLPE did not result in better clinical outcomes than CP.

HXLPE has also been associated with weak mechanical properties, including strength and fatigue resistance and even reduced fracture toughness \[[@CR35], [@CR36]\]. Ries et al. believed that the use of HXLPE in TKA may contribute to mechanical failure and concluded that it should not be used in TKA \[[@CR37], [@CR38]\]. A case was reported in the literature of XLPE post fracture due to the higher local stresses in the posterior-stabilized designs \[[@CR39]\]. Of the six included studies, three indicated that there were no mechanical failures related to the tibial polyethylene in either group. Similarly, the pooled results showed no significant difference. Therefore, we concluded that HXLPE was as safe as CP in TKA.

There are some potential limitations in this meta-analysis. (1) Only three RCTs and three non-RCTs were identified, with small sample sizes and relatively short-term follow-up. (2) Methodological weaknesses existed in all of the studies. (3) Some of the data, such as ROM, are inappropriate for meta-analysis.

Conclusions {#Sec24}
===========

In conclusion, this meta-analysis showed that, compared with CP, HXLPE did not improve the clinical and radiographic outcomes in mid-term follow-up after TKA. Additional high-quality multicenter prospective RCTs with good design, large study populations, and long-term follow-up will be necessary to further clarify the effect of HXLPE in TKA.
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